8/29
07:00 am
agio
Agios to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2023
Low
Report
Agios to Present at the Morgan Stanley Global Healthcare Conference on September 12, 2023
8/17
06:01 am
agio
Agios Pharmaceuticals: Positive Phase 2 Results In Sickle Cell Study [Seeking Alpha]
Low
Report
Agios Pharmaceuticals: Positive Phase 2 Results In Sickle Cell Study [Seeking Alpha]
8/7
04:26 pm
agio
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target lowered by analysts at JPMorgan Chase & Co. from $33.00 to $32.00. They now have a "neutral" rating on the stock.
Low
Report
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target lowered by analysts at JPMorgan Chase & Co. from $33.00 to $32.00. They now have a "neutral" rating on the stock.
8/4
05:52 pm
agio
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q2 2023 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q2 2023 Earnings Call Transcript [Yahoo! Finance]
8/4
06:18 am
agio
Agios Pharmaceuticals Second Quarter 2023 Earnings: Beats Expectations [Yahoo! Finance]
Low
Report
Agios Pharmaceuticals Second Quarter 2023 Earnings: Beats Expectations [Yahoo! Finance]
8/3
12:46 pm
agio
Agios Pharmaceuticals, Inc. (AGIO) Q2 2023 Earnings Call Transcript [Seeking Alpha]
Low
Report
Agios Pharmaceuticals, Inc. (AGIO) Q2 2023 Earnings Call Transcript [Seeking Alpha]
8/3
06:35 am
agio
Agios Reports Business Highlights and Second Quarter 2023 Financial Results
Medium
Report
Agios Reports Business Highlights and Second Quarter 2023 Financial Results
8/3
06:30 am
agio
Agios Announces Exclusive Worldwide License Agreement for Novel siRNA for the Potential Treatment of Polycythemia Vera
Low
Report
Agios Announces Exclusive Worldwide License Agreement for Novel siRNA for the Potential Treatment of Polycythemia Vera
7/18
11:18 am
agio
Should You Buy Agios Pharmaceuticals (AGIO) After Golden Cross? [Yahoo! Finance]
Low
Report
Should You Buy Agios Pharmaceuticals (AGIO) After Golden Cross? [Yahoo! Finance]
7/13
07:00 am
agio
Agios to Webcast Conference Call of Second Quarter 2023 Financial Results on Aug. 3, 2023
Low
Report
Agios to Webcast Conference Call of Second Quarter 2023 Financial Results on Aug. 3, 2023
6/26
06:30 am
agio
Agios Announces Positive Results from Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease with Both Mitapivat Dose Arms Achieving Statistically Significant Hemoglobin Response
Low
Report
Agios Announces Positive Results from Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease with Both Mitapivat Dose Arms Achieving Statistically Significant Hemoglobin Response